GMED
Price
$66.89Alerts
Change
-$1.71 (-2.49%)
Updated
Nov 20 closing price
Capitalization
9.54B
94 days until earnings call
Intraday BUY SELL Signals
SNN
Price
$29.83Alerts
Change
-$0.00 (-0.00%)
Updated
Nov 20 closing price
Capitalization
13.04B
94 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GMED vs SNN

GMED vs SNN Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
GMED vs. SNN commentary
Nov 22, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMED is a Hold and SNN is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for GMED with price predictions
Nov 20, 2026

GMED in downward trend: price dove below 50-day moving average on November 06, 2026

GMED moved below its 50-day moving average on November 06, 2026 date and that indicates a change from an upward trend to a downward trend. In 28 of 43 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 65%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for GMED moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 34 similar instances where the indicator moved out of overbought territory. In 20 of the 34 cases, the stock moved lower in the following days. This puts the odds of a move lower at 59%.

The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GMED as a result. In 48 of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 53%.

The Moving Average Convergence Divergence Histogram (MACD) for GMED turned negative on November 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 26 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 52%.

The 10-day moving average for GMED crossed bearishly below the 50-day moving average on November 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 20 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 50%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GMED declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 57%.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +9.62% 3-day Advance, the price is estimated to grow further. Considering data from situations where GMED advanced for three days, in 203 of 309 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.

GMED may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 121 of 211 cases where GMED Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 57%.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 65 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 73 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.000) is normal, around the industry mean (4.142). P/E Ratio (17.897) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (1.493) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (3.275) is also within normal values, averaging (40.124).

The Tickeron Price Growth Rating for this company is 73 (best 1 - 100 worst), indicating slightly worse than average price growth. GMED’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 83 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GMED’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for SNN with price predictions
Nov 20, 2026

Momentum Indicator for SNN turns negative, indicating new downward trend

SNN saw its Momentum Indicator move below the 0 level on November 18, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 82 similar instances where the indicator turned negative. In 51 of the 82 cases, the stock moved further down in the following days. The odds of a decline are at 62%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for SNN moved out of overbought territory on November 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 34 similar instances where the indicator moved out of overbought territory. In 20 of the 34 cases, the stock moved lower in the following days. This puts the odds of a move lower at 59%.

The Moving Average Convergence Divergence Histogram (MACD) for SNN turned negative on November 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 23 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 46%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SNN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 56%.

SNN broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

SNN moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for SNN crossed bullishly above the 50-day moving average on October 20, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 62%.

Following a +1.03% 3-day Advance, the price is estimated to grow further. Considering data from situations where SNN advanced for three days, in 191 of 331 cases, the price rose further within the following month. The odds of a continued upward trend are 58%.

The Aroon Indicator entered an Uptrend today. In 116 of 202 cases where SNN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 57%.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 51 (best 1 - 100 worst), indicating steady price growth. SNN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 54 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.517) is normal, around the industry mean (4.142). P/E Ratio (20.991) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (1.035) is also within normal values, averaging (11.253). Dividend Yield (0.038) settles around the average of (0.011) among similar stocks. P/S Ratio (1.905) is also within normal values, averaging (40.124).

The Tickeron PE Growth Rating for this company is 80 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SNN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
GMED vs SNN: Fundamental Ratings
GMED
SNN
OUTLOOK RATING
1..100
7058
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
54
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
6592
PRICE GROWTH RATING
1..100
7351
P/E GROWTH RATING
1..100
8380
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNN's Valuation (54) in the Medical Specialties industry is in the same range as GMED (73). This means that SNN’s stock grew similarly to GMED’s over the last 12 months.

SNN's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as GMED (100). This means that SNN’s stock grew similarly to GMED’s over the last 12 months.

GMED's SMR Rating (65) in the Medical Specialties industry is in the same range as SNN (92). This means that GMED’s stock grew similarly to SNN’s over the last 12 months.

SNN's Price Growth Rating (51) in the Medical Specialties industry is in the same range as GMED (73). This means that SNN’s stock grew similarly to GMED’s over the last 12 months.

SNN's P/E Growth Rating (80) in the Medical Specialties industry is in the same range as GMED (83). This means that SNN’s stock grew similarly to GMED’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GMEDSNN
RSI
ODDS (%)
Bearish Trend 2 days ago
59%
Bearish Trend 2 days ago
59%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
62%
Momentum
ODDS (%)
Bearish Trend 2 days ago
53%
Bearish Trend 2 days ago
62%
MACD
ODDS (%)
Bearish Trend 2 days ago
52%
Bearish Trend 2 days ago
46%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
58%
Bearish Trend 2 days ago
56%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
59%
Bullish Trend 2 days ago
59%
Advances
ODDS (%)
Bullish Trend 18 days ago
66%
Bullish Trend 24 days ago
58%
Declines
ODDS (%)
Bearish Trend 2 days ago
57%
Bearish Trend 3 days ago
56%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
62%
Bearish Trend 2 days ago
41%
Aroon
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 2 days ago
57%
COMPARISON
Comparison
Nov 22, 2026
Stock price -- (GMED: $66.89 vs. SNN: $29.83)
Brand notoriety: GMED and SNN are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: GMED: 87% vs. SNN: 91%
Market capitalization -- GMED: $9.54B vs. SNN: $13.04B
GMED [@Medical/Nursing Services] is valued at $9.54B. SNN’s [@Medical/Nursing Services] market capitalization is $13.04B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $190.22B. The average market capitalization across the [@Medical/Nursing Services] industry is $6.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GMED’s FA Score shows that 0 FA rating(s) are green while SNN’s FA Score has 0 green FA rating(s).

  • GMED’s FA Score: 0 green, 5 red.
  • SNN’s FA Score: 0 green, 5 red.
According to our system of comparison, SNN is a better buy in the long-term than GMED.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GMED’s TA Score shows that 4 TA indicator(s) are bullish while SNN’s TA Score has 5 bullish TA indicator(s).

  • GMED’s TA Score: 4 bullish, 6 bearish.
  • SNN’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, SNN is a better buy in the short-term than GMED.

Price Growth

GMED (@Medical/Nursing Services) experienced а -7.28% price change this week, while SNN (@Medical/Nursing Services) price change was -4.64% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -11.44%. For the same industry, the average monthly price growth was -15.18%, and the average quarterly price growth was -18.29%.

Reported Earning Dates

GMED is expected to report earnings on Feb 23, 2027.

SNN is expected to report earnings on Feb 23, 2027.

Industries' Descriptions

@Medical/Nursing Services (-11.44% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

SNN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNN has been loosely correlated with ZBH. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if SNN jumps, then ZBH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNN
1D Price
Change %
SNN100%
N/A
ZBH - SNN
65%
Loosely correlated
-0.36%
MDT - SNN
62%
Loosely correlated
-0.67%
SYK - SNN
60%
Loosely correlated
-0.98%
STE - SNN
59%
Loosely correlated
+0.39%
GMED - SNN
57%
Loosely correlated
-2.49%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
VTIP48.740.15
+0.31%
Vanguard Short-Term Inflation-Protected Securities ETF (VTIP)
BSJS21.43-0.05
-0.25%
Invesco BulletShares 2028 High Yield Corporate Bond ETF (BSJS)
LJAN24.54-0.14
-0.56%
Innovator Premium Income 15 Buffer ETF - January (LJAN)
WOMN41.45-1.04
-2.45%
Impact Shares Womens Empowerment ETF (WOMN)
QQMG41.91-2.64
-5.92%
Invesco ESG NASDAQ 100 ETF (QQMG)